Search by Drug Name or NDC
NDC 54859-0808-08 Senna Syrup 8.8 mg/5mL Details
Senna Syrup 8.8 mg/5mL
Senna Syrup is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Llorens Pharmaceutical International Division, Inc.. The primary component is SENNOSIDES.
MedlinePlus Drug Summary
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
Related Packages: 54859-0808-08Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Senna
Product Information
| NDC | 54859-0808 |
|---|---|
| Product ID | 54859-808_33f62b61-9780-454e-98c1-5d3188ecbdee |
| Associated GPIs | 46200060201220 78310000000100 |
| GCN Sequence Number | 002922 |
| GCN Sequence Number Description | sennosides SYRUP 8.8MG/5ML ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 08660 |
| HICL Sequence Number | 001289 |
| HICL Sequence Number Description | SENNOSIDES |
| Brand/Generic | Generic |
| Proprietary Name | Senna Syrup |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sennosides |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | ORAL |
| Active Ingredient Strength | 8.8 |
| Active Ingredient Units | mg/5mL |
| Substance Name | SENNOSIDES |
| Labeler Name | Llorens Pharmaceutical International Division, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 54859-0808-08 (54859080808)
| NDC Package Code | 54859-808-08 |
|---|---|
| Billing NDC | 54859080808 |
| Package | 237 mL in 1 BOTTLE (54859-808-08) |
| Marketing Start Date | 2019-05-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.03753 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | SENNA 8.8 MG/5 ML SYRUP |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL 5be0163c-b7f7-46db-b738-78c2946a6cf6 Details
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
Warnings
Do not use
- laxative products for longer than 1 week unless directed by a doctor
Ask a doctor or pharmacis before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden changed in bowel movement that continues over a period of 2 weeks
Stope use and ask a doctor if
you have rectal bleeding or failure to have a bowel movemebt after use of laxative. They may indicate a serious condition.
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
- shake well before use
- Do not exceed recommended dose
| Age | Starting Dose | Maximum dosage |
| Adults and children 12 years and older | 2-3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor | 3 teaspoons in the morning and 3 teaspoons at bedtime |
| Under 12 years of age | ask a doctor | ask a doctor |
SPL UNCLASSIFIED SECTION
INGREDIENTS AND APPEARANCE
| SENNA SYRUP
sennosides liquid |
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
| Labeler - Llorens Pharmaceutical International Division, Inc. (037342305) |
| Registrant - Llorens Pharmaceutical International Division, Inc. (037342305) |
Revised: 7/2022
Document Id: 33f62b61-9780-454e-98c1-5d3188ecbdee
Set id: 5be0163c-b7f7-46db-b738-78c2946a6cf6
Version: 2
Effective Time: 20220710